Guido Poggi

1.7k total citations · 1 hit paper
25 papers, 1.1k citations indexed

About

Guido Poggi is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guido Poggi has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 9 papers in Epidemiology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guido Poggi's work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Liver Disease Diagnosis and Treatment (6 papers) and Cancer Mechanisms and Therapy (3 papers). Guido Poggi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Liver Disease Diagnosis and Treatment (6 papers) and Cancer Mechanisms and Therapy (3 papers). Guido Poggi collaborates with scholars based in Italy and United States. Guido Poggi's co-authors include Masao Omata, Éric Raymond, Joong‐Won Park, Xiangqun Song, Liqiang Yang, Masatoshi Kudo, Yoon‐Koo Kang, Ann‐Lii Cheng, Deng‐Yn Lin and Silvana Lanzalone and has published in prestigious journals such as Journal of Clinical Oncology, Rapid Communications in Mass Spectrometry and Journal of Chromatography B.

In The Last Decade

Guido Poggi

24 papers receiving 1.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial

2013 586 citations Ann‐Lii Cheng, Yoon‐Koo Kang et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guido Poggi Italy	13	719	319	259	255	203	25	1.1k
Christian Mueller Austria	5	1.1k 1.5×	286 0.9×	541 2.1×	179 0.7×	236 1.2×	11	1.4k
Kateřina Kubáčková Czechia	15	557 0.8×	288 0.9×	209 0.8×	429 1.7×	309 1.5×	45	1.2k
Davide Pastorelli Italy	19	723 1.0×	310 1.0×	313 1.2×	496 1.9×	391 1.9×	65	1.7k
Călin Cainap Romania	18	450 0.6×	339 1.1×	228 0.9×	376 1.5×	257 1.3×	63	1.5k
Silvia Tremosini Spain	9	943 1.3×	145 0.5×	624 2.4×	155 0.6×	136 0.7×	11	1.3k
Jane Koh Hong Kong	16	849 1.2×	231 0.7×	568 2.2×	493 1.9×	232 1.1×	31	1.7k
Laura Ladrón de Guevara Mexico	8	1.0k 1.4×	311 1.0×	637 2.5×	247 1.0×	144 0.7×	11	1.5k
Philipp K. Haber Germany	16	830 1.2×	195 0.6×	307 1.2×	504 2.0×	409 2.0×	33	1.6k
Lucy Dagher Mexico	15	1.2k 1.6×	287 0.9×	677 2.6×	146 0.6×	132 0.7×	31	1.3k
Zhongguo Zhou China	21	845 1.2×	350 1.1×	358 1.4×	489 1.9×	325 1.6×	87	1.7k

Countries citing papers authored by Guido Poggi

Since Specialization

Citations

This map shows the geographic impact of Guido Poggi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Poggi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Poggi more than expected).

Fields of papers citing papers by Guido Poggi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Poggi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Poggi. The network helps show where Guido Poggi may publish in the future.

Co-authorship network of co-authors of Guido Poggi

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Poggi. A scholar is included among the top collaborators of Guido Poggi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Poggi. Guido Poggi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poggi, Guido. (2015). Microwave ablation of hepatocellular carcinoma. World Journal of Hepatology. 7(25). 2578–2578. 92 indexed citations

Negri, Francesca, Barbara Dal Bello, Camillo Porta, et al.. (2015). Expression of pERK and VEGFR‐2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment. Liver International. 35(8). 2001–2008. 46 indexed citations

Cheng, Ann‐Lii, Yoon‐Koo Kang, Deng‐Yn Lin, et al.. (2013). Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial. Journal of Clinical Oncology. 31(32). 4067–4075. 586 indexed citations breakdown →

Poggi, Guido, et al.. (2013). Unusual case of ascites. International Journal of Case Reports and Images. 4(1). 32–32.

Poggi, Guido, et al.. (2013). Transhepatic percutaneous endoscopic gastrostomy. Open Journal of Gastroenterology. 3(2). 87–88. 3 indexed citations

Sottani, Cristina, Guido Poggi, Fabio Melchiorre, Benedetta Montagna, & Claudio Minoia. (2012). Simultaneous measurement of doxorubicin and reduced metabolite doxorubicinol by UHPLC–MS/MS in human plasma of HCC patients treated with TACE. Journal of Chromatography B. 915-916. 71–78. 29 indexed citations

Palumbo, Raffaella, Antônio Bernardo, Alberto Riccardi, et al.. (2011). Intravenous or Oral Vinorelbine Plus Capecitabine As First-Line Treatment in HER2– Metastatic Breast Cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials. Clinical Breast Cancer. 12(1). 30–39. 11 indexed citations

Poggi, Guido, Benedetta Montagna, Fabio Melchiorre, et al.. (2011). Hepatic intra-arterial cetuximab in combination with 5-fluorouracil and cisplatin as salvage treatment for sorafenib-refractory hepatocellular carcinoma.. PubMed. 31(11). 3927–33. 8 indexed citations

Poggi, Guido, Pietro Quaretti, Benedetta Montagna, et al.. (2010). Acute Thrombocytopenia: An Unusual Complication Occurring After Drug-Eluting Microspheres Transcatheter Hepatic Chemoembolization. CardioVascular and Interventional Radiology. 34(S2). 190–194. 2 indexed citations

10.

Poggi, Guido, Alberto Riccardi, Stefano Tonini, et al.. (2010). Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver.. PubMed. 30(12). 5159–64. 21 indexed citations

11.

Sottani, Cristina, Emanuela Leoni, Benedetta Porro, et al.. (2009). Validation of an LC–MS/MS method for the determination of epirubicin in human serum of patients undergoing Drug Eluting Microsphere-Transarterial Chemoembolization (DEM-TACE). Journal of Chromatography B. 877(29). 3543–3548. 24 indexed citations

12.

Poggi, Guido, Alessio Amatu, Benedetta Montagna, et al.. (2009). OEM-TACE: A New Therapeutic Approach in Unresectable Intrahepatic Cholangiocarcinoma. CardioVascular and Interventional Radiology. 32(6). 1187–1192. 59 indexed citations

13.

Poggi, Guido, Laura Villani, Federico Sottotetti, et al.. (2009). Treatment of Chronic Hepatitis C in a Patient Affected by Systemic Sclerosis. Gastroenterology Research and Practice. 2009. 1–5. 1 indexed citations

14.

Sottani, Cristina, Emanuela Leoni, Guido Poggi, et al.. (2008). Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high‐performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation. Rapid Communications in Mass Spectrometry. 22(17). 2645–2659. 83 indexed citations

15.

Candura, Stefano M., et al.. (2008). Malignant mesothelioma of the tunica vaginalis testis in a petrochemical worker exposed to asbestos.. PubMed. 28(2B). 1365–8. 9 indexed citations

16.

Poggi, Guido, Alberto Riccardi, Pietro Quaretti, et al.. (2007). Complications of percutaneous radiofrequency thermal ablation of primary and secondary lesions of the liver.. PubMed. 27(4C). 2911–6. 21 indexed citations

17.

Poggi, Guido, Carlo Gatti, Mario Melazzini, et al.. (2004). Percutaneous ultrasound-guided radiofrequency thermal ablation of malignant osteolyses.. PubMed. 23(6D). 4977–83. 16 indexed citations

18.

Poggi, Guido, Carlo Gatti, Cristina Teragni, Angelo Delmonte, & Giovanni Di Bernardo. (2004). Radiofrequency ablation combined with percutaneous ethanol injection in the treatment of hepatocellular carcinoma and portal vein neoplastic thrombosis.. PubMed. 24(4). 2419–21. 12 indexed citations

19.

Poggi, Guido, et al.. (2001). Percutaneous US-guided radiofrequency ablation of hepatocellular carcinomas: results in 15 patients.. PubMed. 21(1B). 739–42. 14 indexed citations

20.

Pedrazzoli, Paolo, Gian Antonio Da Prada, P. Preti, et al.. (1991). Evaluation of the Effect of Medroxyprogesterone Acetate on Bone Marrow Progenitor Cells. Tumori Journal. 77(5). 399–402. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact